Research programme: gp96-based vaccines - University of Miami/Zolovax
Latest Information Update: 16 Nov 2016
At a glance
- Originator University of Miami
- Developer University of Miami; Zolovax
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Dengue; HIV infections; West Nile virus infections; Yellow fever; Zika virus infection